NCT02259309View on ClinicalTrials.gov

Immune Modulation by Misoprostol

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

November 30, 2015

Conditions
Gynecological Infection
Interventions
DRUG

Misoprostol - buccal

buccal administration

DRUG

Misoprostol - vaginal

vaginal administration

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

Gynuity Health Projects

OTHER

lead

Vanderbilt University

OTHER

NCT02259309 - Immune Modulation by Misoprostol | Biotech Hunter | Biotech Hunter